Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence studies bridge the gap left from case detection, to estimate the true burden of the COVID-19 pandemic. While multiple anti-SARS-CoV-2 immunoassays are available, no gold standard exists. Methods This serial cross-sectional study was conducted using plasma samples from 8999 healthy blood donors between April-September 2020. Each sample was tested by four assays: Abbott SARS-Cov-2 IgG assay, targeting nucleocapsid (Abbott-NP) and three in-house IgG ELISA assays (targeting spike glycoprotein, receptor binding domain, and nucleocapsid). Seroprevalence rates were compared using multiple composite reference standards and by a series of Bayesian Latent Class Models. Result We found 13 unique diagnostic phenotypes; only 32 samples (0.4%) were positive by all assays. None of the individual assays resulted in seroprevalence increasing monotonically over time. In contrast, by using the results from all assays, the Bayesian Latent Class Model with informative priors predicted seroprevalence increased from 0.7% (95% credible interval (95% CrI); 0.4, 1.0%) in April/May to 0.7% (95% CrI 0.5, 1.1%) in June/July to 0.9% (95% CrI 0.5, 1.3) in August/September. Assay characteristics varied over time. Overall Spike had the highest sensitivity (93.5% (95% CrI 88.7, 97.3%), while the sensitivity of the Abbott-NP assay waned from 77.3% (95% CrI 58.7, 92.5%) in April/May to 64.4% (95% CrI 45.6, 83.0) by August/September. Discussion Our results confirmed very low seroprevalence after the first wave in Canada. Given the dynamic nature of this pandemic, Bayesian Latent Class Models can be used to correct for imperfect test characteristics and waning IgG antibody signals.
【초록키워드】 severe acute respiratory syndrome coronavirus 2, SARS-CoV-2, IgG, coronavirus, pandemic, Bayesian, spike, cross-sectional, COVID-19 pandemic, Seroprevalence, spike glycoprotein, diagnostic, severe acute respiratory syndrome Coronavirus, anti-SARS-CoV-2, Receptor binding domain, immunoassay, sensitivity, Blood donors, cross-sectional study, IgG antibody, Characteristics, nucleocapsid, Model, gold, respiratory, IgG ELISA, Canada, First wave, reference standard, Reference standards, Abbott, credible interval, acute respiratory syndrome, acute respiratory syndrome coronavirus, house, gold standard, plasma samples, class, positive, while, plasma sample, Result, highest, predicted, assays, conducted, can be used, unique, CrI, healthy blood donor, Latent, waned, was tested, 【제목키워드】 SARS-CoV-2, acute respiratory syndrome, gold standard, absence,